Sonia Therapeutics was established in February 2020 to develop a cancer treatment device, the High-Intensity Focused Ultrasound (HIFU) therapy device, utilizing the technology and know-how built up at Tokyo Women's Medical University, Tohoku University, and Tokyo Medical University. HIFU therapy is expected to be a next-generation treatment for cancer because it can be performed repeatedly without radiation exposure. MEDINET is developing the HIFU treatment device as a new modality for pancreatic cancer, one of the most difficult-to-treat cancers.

This Series A financing, the "FY 2020 Next Generation Innovation Creation Project 2020 Grant Program" implemented by the Tokyo Metropolitan Government and the Tokyo Metropolitan Small Business Corporation, and the "Commercialization Support for R&D Startups in the Seed Phase (NEDO-STS)" implemented by the New Energy and Industrial Technology Development Organization (NEDO), will accelerate the development of the next-generation HIFU treatment device and enable us to realize our vision of "bringing a new future to cancer patients. We will accelerate the development of the next-generation HIFU treatment device through the "Next Generation Innovation Creation Project 2020 Grant" from the Japan Science and Technology Agency (JSPS) and the "Commercialization Support for Seed-stage R&D Start-ups (NEDO-STS)" from the New Energy and Industrial Technology Development Organization (NEDO), and strive to realize our vision "to bring a new future to cancer patients through acoustic engineering (ultrasound)" as quickly as possible.
List of investors in this round (in no particular order)
- Fast Track Initiative Inc.
- SBI Investment Co.
- FFG Venture Business Partners, Inc.
- Mitsubishi UFJ Capital Corporation (Head Office: Chuo-ku, Tokyo)
- Japan Science and Technology Agency (JST) (Headquarters: Kawaguchi, Saitama)
- epiST Ventures, Inc.
- MAKOTO CAPITAL Corporation (Head office: Sendai City, Miyagi Prefecture)
- Higin Capital Corporation (Head office: Kumamoto, Kumamoto Prefecture)
| name of company | Sonia Therapeutics, Inc. |
| Establishment | February 2020 |
| capital stock | 1-23-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo TK Shintoshin Bldg. 5F |
| representative | Toru Sato |
| Business Overview | Research and development of focused ultrasound (HIFU) treatment devices |
| uniform resouce locator | https://www.sonire-therapeutics.com |









